Immediate exacerbation of atopic dermatitis after switching from upadacitinib to dupilumab: A report of two cases

• Príomhchruthaitheoirí: Makoto Ito (Údar), Masahiro Kamata (Údar), Hideaki Uchida (Údar), Shota Egawa (Údar), Saki Fukaya (Údar), Kotaro Hayashi (Údar), Atsuko Fukuyasu (Údar), Takamitsu Tanaka (Údar), Takeko Ishikawa (Údar), Yayoi Tada (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Frontiers Media S.A., 2023-10-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Abstract Janus kinase (JAK) inhibitors are efficacious for atopic dermatitis (AD). However, some patients receiving JAK inhibitors develop acne, especially younger patients, or herpes zoster, especially elderly patients, and desire to switch to dupilumab. We experienced two patients with immediate e...